AAAAAA
Results:
1-23
|
Results: 23
Authors:
Larsen, JP
Tandberg, E
Citation: Jp. Larsen et E. Tandberg, Sleep disorders in patients with Parkinson's disease - Epidemiology and management, CNS DRUGS, 15(4), 2001, pp. 267-275
Authors:
Aarsland, D
Ballard, C
McKeith, I
Perry, RH
Larsen, JP
Citation: D. Aarsland et al., Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease, J NEUROP CL, 13(3), 2001, pp. 374-379
Authors:
Aarsland, D
Litvan, I
Larsen, JP
Citation: D. Aarsland et al., Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease, J NEUROP CL, 13(1), 2001, pp. 42-49
Authors:
Aarsland, D
Ballard, C
Larsen, JP
McKeith, I
Citation: D. Aarsland et al., A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia, INT J GER P, 16(5), 2001, pp. 528-536
Authors:
Aarsland, D
Cummings, JL
Larsen, JP
Citation: D. Aarsland et al., Neuropsychiatric differences between Parkinson's disease with dementia andAlzheimer's disease, INT J GER P, 16(2), 2001, pp. 184-191
Authors:
Aarsland, D
Andersen, K
Larsen, JP
Lolk, A
Nielsen, H
Kragh-Sorensen, P
Citation: D. Aarsland et al., Risk of dementia in Parkinson's disease - A community-based, prospective study, NEUROLOGY, 56(6), 2001, pp. 730-736
Authors:
Hegland, O
Dickstein, K
Larsen, JP
Citation: O. Hegland et al., Effect of simvastatin in preventing progression of carotid artery stenosis, AM J CARD, 87(5), 2001, pp. 643-645
Authors:
Beyer, MK
Herlofson, K
Arsland, D
Larsen, JP
Citation: Mk. Beyer et al., Causes of death in a community-based study of Parkinson's disease, ACT NEUR SC, 103(1), 2001, pp. 7-11
Authors:
Larsen, JP
Karlsen, K
Tandberg, E
Citation: Jp. Larsen et al., Clinical problems in non-fluctuating patients with Parkinson's disease: A community-based study, MOVEMENT D, 15(5), 2000, pp. 826-829
Authors:
Arsland, D
Larsen, JP
Lim, NG
Wermuth, L
Bech, P
Citation: D. Arsland et al., alpha(2)-adrenoreceptor antagonism and serotonin reuptake inhibition in patients with Parkinson disease and depression, NORD J PSY, 54(6), 2000, pp. 411-415
Authors:
Karlsen, KH
Tandberg, E
Arsland, D
Larsen, JP
Citation: Kh. Karlsen et al., Health related quality of life in Parkinson's disease: a prospective longitudinal study, J NE NE PSY, 69(5), 2000, pp. 584-589
Authors:
Aarsland, D
Larsen, JP
Tandberg, E
Laake, K
Citation: D. Aarsland et al., Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study, J AM GER SO, 48(8), 2000, pp. 938-942
Authors:
Larsen, JP
Boas, J
Erdal, JE
Citation: Jp. Larsen et al., Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study, EUR J NEUR, 6(5), 1999, pp. 539-547
Authors:
Jorga, KM
Larsen, JP
Beiske, A
Schleimer, M
Fotteler, B
Schmitt, M
Moe, B
Citation: Km. Jorga et al., The effect of tolcapone on the pharmacokinetics of beserazide, EUR J NEUR, 6(2), 1999, pp. 211-219
Authors:
Aarsland, D
Larsen, JP
Lim, NG
Tandberg, E
Citation: D. Aarsland et al., Olanzapine for psychosis in patients with Parkinson's disease with and without dementia, J NEUROP CL, 11(3), 1999, pp. 392-394
Authors:
Aarsland, D
Larsen, JP
Karlsen, K
Lim, NG
Tandberg, E
Citation: D. Aarsland et al., Mental symptoms in Parkinson's disease are important contributors to caregiver distress, INT J GER P, 14(10), 1999, pp. 866-874
Authors:
Tandberg, E
Larsen, JP
Karlsen, K
Citation: E. Tandberg et al., Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community-based study, MOVEMENT D, 14(6), 1999, pp. 922-927
Authors:
Karlsen, K
Larsen, JP
Tandberg, E
Jorgensen, K
Citation: K. Karlsen et al., Fatigue in patients with Parkinson's disease, MOVEMENT D, 14(2), 1999, pp. 237-241
Authors:
Korczyn, AD
Brunt, ER
Larsen, JP
Nagy, Z
Poewe, WH
Ruggieri, S
Citation: Ad. Korczyn et al., A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease, NEUROLOGY, 53(2), 1999, pp. 364-370
Authors:
Myhr, KM
Riise, T
Lilleas, FEG
Beiske, TG
Celius, EG
Edland, A
Jensen, D
Larsen, JP
Nilsen, R
Nortvedt, MW
Smievoll, AI
Vedeler, C
Nyland, HI
Citation: Km. Myhr et al., Interferon-alpha 2a reduces MRI disease activity in relapsing-remitting multiple sclerosis, NEUROLOGY, 52(5), 1999, pp. 1049-1056
Authors:
Aarsland, D
Larsen, JP
Lim, NG
Janvin, C
Karlsen, K
Tandberg, E
Cummings, JL
Citation: D. Aarsland et al., Range of neuropsychiatric disturbances in patients with Parkinson's disease, J NE NE PSY, 67(4), 1999, pp. 492-496
Authors:
Karlsen, KH
Larsen, JP
Tandberg, E
Maeland, JG
Citation: Kh. Karlsen et al., Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease, J NE NE PSY, 66(4), 1999, pp. 431-435
Authors:
Aarsland, D
Larsen, JP
Cummings, JL
Laake, K
Citation: D. Aarsland et al., Prevalence and clinical correlates of psychotic symptoms in Parkinson disease - A community-based study, ARCH NEUROL, 56(5), 1999, pp. 595-601
Risultati:
1-23
|